Early erythropoietin use for the prevention of anemia in very low birth weight newborns;Uso precoz de la eritropoyetina en la prevención de la anemia del prematuro

Revista Medica de Chile

Volumn 128, Issue 12, 2000, Pages 1313-1317

  Salvadó G, Antonio ^c   Ramolfo B, Pamela ^d   Escobar M, Marisol ^d   Núñez C, Alejandra ^d   Aguayo T, Inés ^d   Standen H, Jane ^d   Sánchez G, Lina ^a   Cabello M, Angela ^b  

^a UNIVERSIDAD DE VALPARAÍSO   (Chile)

^b Hospital Dr Gustavo Fricke   (Chile)

^c Eklonia 565 Dpto 38   (Chile)

^d NONE

Author keywords

Anemia neonatal; Erythropoietin; Infant, low birth weight

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LOW BIRTH WEIGHT; MALE; NEWBORN; NEWBORN ANEMIA; RANDOMIZED CONTROLLED TRIAL; TIME; UTILIZATION REVIEW;

ANEMIA, NEONATAL; BLOOD TRANSFUSION; DOUBLE-BLIND METHOD; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; TIME FACTORS;

EID: 0346976487     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. OBLADEN M, SACHSENWEGER M, STAHKNE. M. Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr 1988; 147: 399-404.
2. BEDNAREK FJ, WEISBERGER S, RICHARDSON DK, FRANTZ III ID, SHAH B, RUBIN L. Variations in blood transfusions among newborn intensive care units. J Pediatr 1998; 133: 601-7.
3. NEXO E, CHRISTENSEN NC, OLESEN H. Volume of blood removed for analytical purposes during hospitalization of low birth-weight infants. Clin Chem 1981; 27: 759-61.
4. DALLMAN PR. Anemia of Prematurity. Ann Rev Med 1981; 32: 143-60.
5. BROWN MS, GARCIA JF, PHIBBS RH, DALLMAN PR. Erythropoietin production in the human fetus and newborn. Ann NY Acad Sci 1968; 149: 576-7.
6. BROWN MS, PHIBBS RH, GARCIA JF. Postnatal change in erythropoietin levels in untransfunded premature infants. J Pediatr 1983; 103: 612-7.
7. HALVORSEN S, FINNE PH. Decreased response of plasma immunoreactive erythropoietin to avalaible oxygen in anemia of prematurity. J Pediatr 1984; 105: 793.
8. HALPERIN DS, WACKER P, LACOURT G, FELIX M, BABEL JF, AAPRO M, ET AL. Effects of recombinant erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr 1990; 116: 779-86.
9. SHANNON K, MENTZER W, ABELS RJ, FREEMAN P, NEWTON N, THOMPSON D, ET AL. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr 1991; 118: 949-55.
10. SALVADÓ A, SCHERER S, VALDEBENITO C, TAPIA S, ROJAS I. Human Recombinant erythropoietin in preterm newborn infants. Rev Chil Pediatr 1994; 65: 28-31.
11. BLAJCHMAN MA, SHERIDAN D, RAWLS LE. Risks associated with blood transfusions in newborn infants. Clin Perinatol 1984; 11: 403-15.
12. RD, MENTZER WC, EHRENKRANZ RA, BROWN MS, WIDNESS JA, ET AL. Recombinant Human Erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight infants. Pediatrics 1995; 95: 1-8.
13. OHLS RK, OSBORNE KA, CHRISTENSEN RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized-placebo controlled trial. J Pediatr 1995; 126: 421-6.
14. ZACHEE P. Controversies in selection of epoietin dosages. Drugs 1995; 49: 536-47.
15. MAIER RF, OBLADEN M, SCIGALLA P, LINDERKAMP O, DUC G, HIERONIMI G, ET AL. The effect of epoietin beta (recombinant human erythropoietin) on the need for transfusion in very low birth weight infants. N Engl J Med 1994; 330: 11737-8.
16. LIMA-ROGEL V. Efficacy of early erythropoietin use in critically ill very-low-birthweight premature newborn infants: controlled clinical trial. Sangre (Barc) 1998; 43: 191-5.
17. KRALLIS N, CHOLERAS V, MAVRIDIS A, GEORGIOU I, BOURANTAS K, ANDRONICOU S. Effect of Recombinant Human Erythropoietin in preterm infants. Eur J Haematol 1999; 63: 71-6.
18. KUMAR P, SHANKARAN S, KRISHNAN RG. Recombinant Human Erythropoietin therapy for treatment of anemia of prematurity in very low-birthweight infants: randomized, double blind, placebo controlled trial. J Perinatol 1998; 18: 173-7.
19. THE INTERNATIONAL NEONATAL NETWORK. The CRIB (clinical risk index) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. The Lancet 1993; 342: 193-8.
20. SOUBASI V, KREMENOPOULOS G, DIAMANTI E, TSANTALI C, SARAFIDIS K, TSAKIRIS D: Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr 1995; 127: 291-7.
21. MAIER RF, OBLADEN M, KATTNER E, NATZSCHKA J, MASSER J, REGAZZONI BN ET AL. High versus low-dose erythropoietin in extremely low birth weight infants. J Pediatr 1998; 132: 866-70.
22. MEYER MP, MEYER JH, COMMERFORD A, HANN FM, SIVE AA, MOLLER G. Recombinant Human Erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 1994; 93: 918-23.
23. TESTA M, REALI A, COPULA M, PINNA B, BIROCCHI F, PISU C, ET AL. Role of rHuEpo on blood transfusions in preterm infants after the fifteenth day of life. Pediatr Hematol Oncol 1998; 15: 415-20.
24. OHLS RK, OSBORNE KA, CHRISTENSEN RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomised, placebo controlled trial. J Pediatr 1995; 126: 421-6.
25. BIFANO EM, CURRAN T. Minimizing blood donor exposure in the neonatal intensive care unit. Current trends and future prospects. Clin Perinatol 1995; 22: 657-69.